BeOne Medicines: Major biotech relocation strengthens Swiss pharma hub

Former BeiGene company moves headquarters from Cayman Islands to Basel, reinforcing Switzerland's position as global biotech center

Key Takeaways

BeiGene is officially changing its name to BeOne Medicines.
The company is moving its legal headquarters from the Cayman Islands to Basel, Switzerland.
BeOne Medicines was founded in 2010.
The company established its first presence in Basel in 2018 and opened European headquarters there in 2022.

By The Numbers

11,000

Global employees

265

Basel-based employees

Initial Basel employees

They Said

"I am delighted that we have succeeded in attracting BeOne Medicines, an innovative global oncology company, to Basel."
— Kaspar Sutter

"This relocation emphasises the company’s strong commitment to the region and strengthens Basel’s status as one of the leading life science clusters in Europe."
— Kaspar Sutter

Global Biotech Giant Anchors in Basel

Workforce Surges in Historic Expansion

Joining the Titans of Pharma

Strategic Pivot for Oncology Innovation

Sources & References

Biotech company BeiGene renames and relocates to Basel

SWI swissinfo.ch